Miglis Mitchell G, Schneider Logan, Kim Paul, Cheung Joseph, Trotti Lynn Marie
Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
Stanford Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Redwood City, California.
J Clin Sleep Med. 2020 May 15;16(5):749-756. doi: 10.5664/jcsm.8344. Epub 2020 Feb 10.
We aimed to quantify the symptoms of autonomic nervous system dysfunction in a large online cohort of patients with idiopathic hypersomnia, and to determine how the severity of these symptoms interacts with sleepiness, fatigue, and quality of life.
One hundred thirty-eight patients with idiopathic hypersomnia and 81 age- and sex-matched controls were recruited through the website of the Hypersomnia Foundation, a US-based patient advocacy group. Twenty-four patients with confirmed idiopathic hypersomnia were selected by the study investigators as a comparison group. All participants completed a battery of online sleep, autonomic, and quality of life questionnaires including the composite autonomic symptom score-31 (COMPASS-31).
Online and confirmed patients reported significantly higher COMPASS-31 scores (median [interquartile range]) (43.6 [33.6-52.7] and 32.9 [21.7-46.8] vs 17.6 [11.7-27.9], P < .001), with the greatest symptom burden in the orthostatic and vasomotor domains. Online and confirmed patients reported more sleepiness (Epworth sleepiness scale), whereas only online patients reported more fatigue (Chalder fatigue scale). Both the Epworth sleepiness scale and Chalder fatigue scale positively correlated with COMPASS-31 scores. Patients reported lower quality of life as reflected by lower scores across all domains of the RAND 36-item health survey, which was negatively correlated with COMPASS-31 scores.
Symptoms of autonomic nervous system dysfunction are common in idiopathic hypersomnia. In addition, autonomic nervous system symptom burden was positively correlated with sleepiness and negatively correlated with quality of life.
我们旨在对大量特发性嗜睡症患者在线队列中的自主神经系统功能障碍症状进行量化,并确定这些症状的严重程度如何与嗜睡、疲劳及生活质量相互作用。
通过美国患者倡导组织嗜睡症基金会的网站招募了138例特发性嗜睡症患者以及81例年龄和性别匹配的对照者。研究调查人员挑选出24例确诊为特发性嗜睡症的患者作为比较组。所有参与者均完成了一系列在线睡眠、自主神经及生活质量问卷,包括综合自主神经症状评分-31(COMPASS-31)。
在线患者和确诊患者报告的COMPASS-31评分显著更高(中位数[四分位间距])(分别为43.6[33.6 - 52.7]和32.9[21.7 - 46.8],而对照组为17.6[11.7 - 27.9],P <.001),其中体位性和血管舒缩性领域的症状负担最重。在线患者和确诊患者报告有更多嗜睡(爱泼沃斯嗜睡量表),而只有在线患者报告有更多疲劳(查尔德疲劳量表)。爱泼沃斯嗜睡量表和查尔德疲劳量表均与COMPASS-31评分呈正相关。患者报告的生活质量较低,这体现在兰德36项健康调查所有领域的得分较低,且与COMPASS-31评分呈负相关。
自主神经系统功能障碍症状在特发性嗜睡症中很常见。此外,自主神经系统症状负担与嗜睡呈正相关,与生活质量呈负相关。